Additionally, the relatively rare occurrence of ROS1 fusion in NSCLC constrained the size of the patient cohort, potentially limiting the representativeness of our sample for the broader ROS1 fusion-positive population. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.